Aardvark Therapeutics Faces Securities Fraud Investigation

The Law Offices of Frank R. Cruz announced investigations into five companies—Aardvark Therapeutics, Taboola, Parsons, Rollins, and Replimune—for potential federal securities-law violations amid adverse disclosures and ensuing investor losses. The reports span halted trials and FDA concerns to earnings misses, underscoring ongoing legal action by the firm on behalf of affected shareholders.